Institute For Wealth Management, Llc. Vertex Pharmaceuticals Inc Transaction History

Institute For Wealth Management, Llc.

$781 Million
Q3 2024

A detailed history of Institute For Wealth Management, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 3,639 shares of VRTX stock, worth $1.64 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,639

Previous 3,586 1.48%

Holding current value

$1.64 Million

Previous $1.68 Million 0.71%

% of portfolio

0.22%

Previous 0.23%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $24,380 - $26,806	53 Added 1.48%	3,639 $1.69 Million
Q2 2024 Jul 25, 2024	BUY	$392.81 - $485.53 $8,641 - $10,681	22 Added 0.62%	3,586 $1.68 Million
Q4 2023 Jan 31, 2024	SELL	$343.0 - $410.68 $1,372 - $1,642	-4 Reduced 0.11%	3,564 $1.45 Million
Q3 2023 Oct 13, 2023	SELL	$338.18 - $362.46 $3,043 - $3,262	-9 Reduced 0.25%	3,568 $1.24 Million
Q2 2023 Jul 25, 2023	SELL	$314.42 - $351.91 $15,092 - $16,891	-48 Reduced 1.32%	3,577 $1.26 Million
Q4 2022 Feb 02, 2023	SELL	$285.76 - $321.48 $11,144 - $12,537	-39 Reduced 1.06%	3,625 $1.05 Million
Q1 2022 Apr 29, 2022	SELL	$221.42 - $260.97 $13,063 - $15,397	-59 Reduced 1.58%	3,664 $956,000
Q4 2021 Jan 21, 2022	SELL	$177.01 - $223.45 $1,947 - $2,457	-11 Reduced 0.29%	3,723 $818,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $4,534 - $5,074	-25 Reduced 0.67%	3,734 $677,000
Q2 2021 Jul 21, 2021	SELL	$187.49 - $221.1 $10,311 - $12,160	-55 Reduced 1.44%	3,759 $758,000
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $29,810 - $34,748	144 Added 3.92%	3,814 $820,000
Q4 2020 Feb 01, 2021	SELL	$207.01 - $276.09 $16,974 - $22,639	-82 Reduced 2.19%	3,670 $867,000
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $7,158 - $8,486	-28 Reduced 0.74%	3,752 $1.02 Million
Q2 2020 Jul 30, 2020	SELL	$225.48 - $295.8 $20,518 - $26,917	-91 Reduced 2.35%	3,780 $1.1 Million
Q1 2020 Apr 29, 2020	SELL	$199.77 - $247.81 $149,627 - $185,609	-749 Reduced 16.21%	3,871 $921,000
Q4 2019 Feb 27, 2020	BUY	$166.71 - $223.91 $601,656 - $808,091	3,609 Added 356.97%	4,620 $1.01 Million
Q4 2019 Jan 27, 2020	SELL	$166.71 - $223.91 $607,491 - $815,928	-3,644 Reduced 78.28%	1,011 $1.01 Million
Q3 2019 Oct 28, 2019	SELL	$166.23 - $187.09 $4,321 - $4,864	-26 Reduced 0.56%	4,655 $789,000
Q2 2019 Aug 02, 2019	SELL	$164.61 - $190.37 $43,950 - $50,828	-267 Reduced 5.4%	4,681 $858,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $6,549 - $7,788	-40 Reduced 0.8%	4,948 $910,000
Q4 2018 Feb 08, 2019	BUY	$151.91 - $192.21 $757,727 - $958,743	4,988 New	4,988 $826,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $752,845 - $879,627	-4,966 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $681,732 - $772,461	4,966 New	4,966 $743,000
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $799,013 - $875,122	-5,394 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	5,394	5,394 $694,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.

Account

Institute For Wealth Management, Llc. Vertex Pharmaceuticals Inc Transaction History